EveryIntel

Kinea Bio, Inc.

Publicly observed

Mukilteo, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

ItemValueSourceStatus
CountryUSNIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
City / localityMukilteoNIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
NameKinea Bio, Inc.NIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed
UEI (U.S. federal entity ID)HMHJT133QNH1NIH RePORTER (opens in a new tab)
28 Sept 2026
Publicly observed

Recorded events

  1. Grant23 Sept 2026Publicly observed

    NIH SBIR/STTR award: Scalable Non-viral Gene Delivery for Neuromuscular Diseases

    USD 1,021,458.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)

  2. Grant1 Sept 2026Publicly observed

    NIH SBIR/STTR award: Split-Intein Protein Ligation: Enabling AAV Delivery of Large Genes for Clinical Translation in Genetic Cardiac Diseases

    USD 599,669.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)

  3. Grant15 Sept 2025Publicly observed

    NIH SBIR/STTR award: Scalable Non-viral Gene Delivery for Neuromuscular Diseases

    USD 306,859.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)

  4. Grant19 Sept 2024Publicly observed

    NIH SBIR/STTR award: Development of novel genetic medicine approaches to treat orphan diseases

    USD 796,218.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)

  5. Grant19 Sept 2024Publicly observed

    NIH SBIR/STTR award: Development of novel genetic medicine approaches to treat orphan diseases

    USD 55,000.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)

  6. Grant19 Sept 2024Publicly observed

    NIH SBIR/STTR award: Development of novel genetic medicine approaches to treat orphan diseases

    USD 1,159,305.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.